Janice is ready to address her long-standing hyperglycemia from T2D. In the past she has attempted behavioral modifications and taken metformin on and off, and reports being attentive to using the medication, implementing a better diet, and engaging in regular physical activity over the last 6 months to improve her glycemic control and lose weight. Her A1C has improved from 11% to 8.2%. Today she is willing to initiate a second-line therapy to manage her diabetes. She expresses preference for a medication class that will help her lose additional weight. Based on this information, which therapeutic options are reasonable for her at this time? A. Sulfonylurea, DPP-1 inhibitor, or basal insulin B. GLP-1 RA or a thiazolidinedione C. SGLT2 inhibitor or a GLP-1 RA D. Basal insulin or a DPP-1 inhibitor
[Solved]: Janice is ready to address her long-standing…
Need help with your Endocrine & Metabolic Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.